Related references
Note: Only part of the references are listed.Selective brain regional changes in lipid profile with human aging
Natalia Mota-Martorell et al.
GEROSCIENCE (2022)
Knowledge and Attitudes Concerning Aducanumab Among Older Americans After FDA Approval for Treatment of Alzheimer Disease
Julie Zissimopoulos et al.
JAMA NETWORK OPEN (2022)
The multimodal action of genistein in Alzheimer's and other age-related diseases
Cristina Mas-Bargues et al.
FREE RADICAL BIOLOGY AND MEDICINE (2022)
Genistein, a tool for geroscience
Cristina Mas-Bargues et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2022)
A Mini-Review of Flavone Isomers Apigenin and Genistein in Prostate Cancer Treatment
Xiaozhen Ji et al.
FRONTIERS IN PHARMACOLOGY (2022)
Lifelong soya consumption in males does not increase lifespan but increases health span under a metabolic stress such as type 2 diabetes mellitus
Consuelo Borras et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2021)
Targeting Alzheimer's disease with multimodal polypeptide-based nanoconjugates
A. Duro-Castano et al.
SCIENCE ADVANCES (2021)
Pipeline choices alter neuroimaging findings
Martin Lindquist
NATURE (2020)
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia
Michael J. Pontecorvo et al.
BRAIN (2019)
Emerging Signal Regulating Potential of Genistein Against Alzheimer's Disease: A Promising Molecule of Interest
Md Sahab Uddin et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
Sudeepti Southekal et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
Michael D. Devous et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Redox proteomic profiling of neuroketal-adducted proteins in human brain: Regional vulnerability at middle age increases in the elderly
Mayelin Dominguez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Clearing Amyloid-beta through PPAR gamma/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease
Vicent Bonet-Costa et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease
Carey E. Gleason et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Bioavailability and Pharmacokinetics of Genistein: Mechanistic Studies on its ADME
Zhen Yang et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Anterior Cingulate Cortex: Unique Role in Cognition and Emotion
Francis L. Stevens et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2011)
Genistein ameliorates learning and memory deficits in amyloid β(1-40) rat model of Alzheimer's disease
Maryam Bagheri et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2011)
Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPARγ expression in cultured astrocytes
Soraya L. Valles et al.
BRAIN RESEARCH (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women
Carey E. Gleason et al.
AGE AND AGEING (2009)
Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population
L. Rami et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Dietary soy isoflavone-induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo
K Mahn et al.
FASEB JOURNAL (2005)
Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease
C Hock et al.
NATURE MEDICINE (2002)
Share Paper
